Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Colorectal Neoplasms and SLCO1B1[original query] |
---|
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study. Cancer biology & therapy 2011 Nov 12 (9): 780-7. Di Martino Maria Teresa, Arbitrio Mariamena, Leone Emanuela, Guzzi Pietro Hiram, Rotundo Maria Saveria, Ciliberto Domenico, Tomaino Vera, Fabiani Fernanda, Talarico Danilo, Sperlongano Pasquale, Doldo Patrizia, Cannataro Mario, Caraglia Michele, Tassone Pierfrancesco, Tagliaferri Pierosand |
Influence of the functional polymorphisms in the organic anion transporting polypeptide 1B1 in the susceptibility to colorectal cancer. Genetic testing and molecular biomarkers 2013 Mar 17 (3): 214-8. Ozhan Gül, Kara Mehtap, Sari Fatih M, Yanar Hakan T, Alpertunga Buk |
SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer. PloS one 2013 8 (10): e77223. Huang Liu, Zhang Tao, Xie Conghua, Liao Xin, Yu Qianqian, Feng Jueping, Ma Hong, Dai Jing, Li Min, Chen Jigui, Zang Aihua, Wang Qian, Ge Shuwang, Qin Kai, Cai Juan, Yuan Xiangl |
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Pharmacogenetics and genomics 2015 Sep . Chen Sylvia, Villeneuve Lyne, Jonker Derek, Couture Félix, Laverdière Isabelle, Cecchin Erica, Innocenti Federico, Toffoli Giuseppe, Lévesque Eric, Guillemette Chant |
A subset of genetic susceptibility variants for colorectal cancer also has prognostic value. The pharmacogenomics journal 2015 May . Noci S, Dugo M, Bertola F, Melotti F, Vannelli A, Dragani T A, Galvan |
OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. British journal of cancer 2015 Mar 112 (5): 857-65. Teft W A, Welch S, Lenehan J, Parfitt J, Choi Y-H, Winquist E, Kim R |
Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine. Tumori 2018 12 106 (2): 87-94. Paulík Adam, Nekvindová Jana, Filip Stanisl |
Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2757-2764. Treenert Apatsara, Areepium Nutthada, Tanasanvimon Suebpo |
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers. Cancer chemotherapy and pharmacology 2021 2 87 (6): 767-777. Kobayashi Kazuo, Sugiyama Erika, Shinozaki Eiji, Wakatsuki Takeru, Tajima Masataka, Kidokoro Hiyori, Aoyama Takeshi, Nakano Yasuhiro, Kawakami Kazuyoshi, Hashimoto Koki, Suenaga Mitsukuni, Ichimura Takashi, Ogura Mariko, Chin Keisho, Nakayama Izuma, Ooki Akira, Takahari Daisuke, Suzuki Wataru, Yokokawa Takashi, Minowa Yuichi, Hiraoka Tomoko, Suzuki Kenichi, Sato Hitoshi, Hama Toshihiro, Yamaguchi Kens |
- Page last reviewed:Feb 1, 2024
- Content source: